Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrients ; 8(12)2016 Dec 17.
Article in English | MEDLINE | ID: mdl-27999319

ABSTRACT

Physical activity and the ingestion of dietary fiber are non-drug alternatives commonly used as adjuvants to glycemic control in diabetic individuals. Among these fibers, we can highlight beta-glucans. However, few studies have compared isolated and synergic effects of physical exercise and beta-glucan ingestion, especially in type 2 diabetic rats. Therefore, we evaluated the effects beta-glucan (Saccharomyces cerevisiae) consumption, associated or not to exercise, on metabolic parameters of diabetic Wistar rats. The diabetes mellitus (DM) was induced by high-fat diet (HFD) associated with a low dose of streptozotocin (STZ-35 mg/kg). Trained groups were submitted to eight weeks of exercise in aquatic environment. In the last 28 days of experiment, animals received 30 mg/kg/day of beta-glucan by gavage. Isolated use of beta-glucan decreased glucose levels in fasting, Glycated hemoglobin (HbA1c), triglycerides (TAG), total cholesterol (TC), low-density lipoprotein (LDL-C), the atherogenic index of plasma. Exercise alone also decreased blood glucose levels, HbA1c, and renal lesions. An additive effect for reducing the atherogenic index of plasma and renal lesions was observed when both treatments were combined. It was concluded that both beta-glucan and exercise improved metabolic parameters in type 2 (HFD/STZ) diabetic rats.


Subject(s)
Atherosclerosis/prevention & control , Diabetes Mellitus, Experimental/therapy , Diabetes Mellitus, Type 2/therapy , Diabetic Angiopathies/prevention & control , Dietary Fiber/administration & dosage , Dietary Supplements , Exercise Therapy , Saccharomyces cerevisiae/metabolism , beta-Glucans/administration & dosage , Animals , Atherosclerosis/blood , Atherosclerosis/diagnosis , Atherosclerosis/etiology , Biomarkers/blood , Blood Glucose/metabolism , Combined Modality Therapy , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/diagnosis , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/chemically induced , Diabetes Mellitus, Type 2/diagnosis , Diabetic Angiopathies/blood , Diabetic Angiopathies/diagnosis , Diabetic Angiopathies/etiology , Diabetic Nephropathies/etiology , Diabetic Nephropathies/prevention & control , Diet, High-Fat , Glycated Hemoglobin/metabolism , Lipids/blood , Male , Rats, Wistar , Streptozocin , beta-Glucans/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...